As in patient samples, in HCC cell lines, ZEB1 is able to downregulate the expression of E-cadherin and increase the expression of mesenchymal markers such as Vimentin, matrix metallopeptidase 2 (MMP2) and MMP9, contributing to the migration and invasion of these cells [91,109,110]. Here, ZEB1 is linked to hepatocellular carcinoma.